In conclusion, we found that increased expression of SGLT2 could result in an imbalance of Th17/Treg cells in the kidney via activation of the SGK1/p‐Foxo1/IL‐23R pathway and that this underlies DKD pathogenesis. This evidence concerns the gene SGK1 and diabetic kidney disease.